Yang Hongfu, Li Pingna, Cui Qiumin, Ma Ning, Liu Qilong, Sun Xiaoge, Sun Rongqing
Department of Intensive Care Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China. Corresponding author: Sun Rongqing, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Jul;35(7):702-706. doi: 10.3760/cma.j.cn121430-20221230-01135.
To explore the characteristics of changes in peripheral blood lymphocyte subsets in patients with sepsis in intensive care unit (ICU) and analyze their predictive value for prognosis.
The clinical data of sepsis patients admitted to the surgical intensive care unit (SICU) of the First Affiliated Hospital of Zhengzhou University from January 2020 to December 2021 were analyzed retrospectively. The patients met the diagnostic criteria of Sepsis-3 and were ≥ 18 years old. Peripheral venous blood samples were collected from all patients on the next morning after admission to SICU for routine blood test and peripheral blood lymphocyte subsets. According to the 28-day survival, the patients were divided into two groups, and the differences in immune indexes between the two groups were compared. Logistic regression analysis was used to analyze the risk factors of immune indexes that affect prognosis.
(1) A total of 279 patients with sepsis were enrolled in the experiment, of which 198 patients survived at 28 days (28-day survival rate 71.0%), and 81 patients died (28-day mortality 29.0%). There were no significant differences in age (years old: 57.81±1.71 vs. 54.99±1.05) and gender (male: 60.5% vs. 63.6%) between the death group and the survival group (both P > 0.05), and the baseline data was comparable.(2) Acute physiology and chronic health evalution II (APACHE II: 22.06±0.08 vs. 14.08±0.52, P < 0.001), neutrophil percentage [NEU%: (88.90±1.09)% vs. (84.12±0.77)%, P = 0.001], procalcitonin [PCT (μg/L): 11.97±2.73 vs. 5.76±1.08, P = 0.011], platelet distribution width (fL: 16.81±0.10 vs. 16.57±0.06, P = 0.029) were higher than those in the survival group, while lymphocyte percentage [LYM%: (6.98±0.78)% vs. (10.59±0.86)%, P = 0.012], lymphocyte count [LYM (×10/L): 0.70±0.06 vs. 0.98±0.49, P = 0.002], and platelet count [PLT (×10/L): 151.38±13.96 vs. 205.80±9.38, P = 0.002], and thrombocytocrit [(0.15±0.01)% vs. (0.19±0.07)%, P = 0.012] were lower than those in the survival group. (3) There was no statistically significant difference in the percentage of lymphocyte subsets between the death group and the survival group, but the absolute value of LYM (pieces/μL: 650.24±84.67 vs. 876.64±38.02, P = 0.005), CD3 absolute value (pieces/μL: 445.30±57.33 vs. 606.84±29.25, P = 0.006), CD3CD4 absolute value (pieces/μL: 239.97±26.96 vs. 353.49±18.59, P = 0.001), CD19 absolute value (pieces/μL: 111.10±18.66 vs. 150.30±10.15, P = 0.049) in the death group was lower than those in the survival group. Other lymphocyte subsets in the death group, such as CD3CD8 absolute value (pieces/μL: 172.40±24.34 vs. 211.22±11.95, P = 0.112), absolute value of natural killer cell [NK (pieces/μL): 101.26±18.15 vs. 114.72±7.64, P = 0.420], absolute value of natural killer T cell [NKT (pieces/μL): 33.22±5.13 vs. 39.43±2.85, P = 0.262], CD4CD8 absolute value (pieces/μL: 41.07±11.07 vs. 48.84±3.31, P = 0.510), CD4CD8 absolute value (pieces/μL: 3.39±1.45 vs. 3.47±0.36, P = 0.943) were not significantly different from those in the survival group. (4)Logistic regression analysis showed that lymphocyte subsets were not selected as immune markers with statistical significance for the prognosis of sepsis.
The changes of immune indexes in sepsis patients are closely related to their prognosis. Early monitoring of the above indexes can accurately evaluate the condition and prognosis of sepsis patients.
探讨重症监护病房(ICU)脓毒症患者外周血淋巴细胞亚群的变化特征,并分析其对预后的预测价值。
回顾性分析2020年1月至2021年12月郑州大学第一附属医院外科重症监护病房(SICU)收治的脓毒症患者的临床资料。患者符合Sepsis-3诊断标准且年龄≥18岁。所有患者于入住SICU后的次日清晨采集外周静脉血样本,进行血常规及外周血淋巴细胞亚群检测。根据28天生存率将患者分为两组,比较两组免疫指标的差异。采用Logistic回归分析影响预后的免疫指标危险因素。
(1)共纳入279例脓毒症患者进行实验,其中198例患者在28天时存活(28天生存率71.0%),81例患者死亡(28天死亡率29.0%)。死亡组与存活组在年龄(岁:57.81±1.71 vs. 54.99±1.05)和性别(男性:60.5% vs. 63.6%)方面无显著差异(均P>0.05),基线资料具有可比性。(2)急性生理与慢性健康状况评分系统II(APACHE II:22.06±0.08 vs. 14.08±0.52,P<0.001)、中性粒细胞百分比[NEU%:(88.90±1.09)% vs. (84.12±0.77)%,P = 0.001]、降钙素原[PCT(μg/L):11.97±2.73 vs. 5.76±1.08,P = 0.011]、血小板分布宽度(fL:16.81±0.10 vs. 16.57±0.06,P = 0.029)高于存活组,而淋巴细胞百分比[LYM%:(6.98±0.78)% vs. (10.59±0.86)%,P = 0.012]、淋巴细胞计数[LYM(×10/L):0.70±0.06 vs. 0.98±0.49,P = 0.002]、血小板计数[PLT(×10/L):151.38±13.96 vs. 205.80±9.38,P = 0.002]以及血小板压积[(0.15±0.01)% vs. (0.19±0.07)%,P = 0.012]低于存活组。(3)死亡组与存活组淋巴细胞亚群百分比无统计学差异,但死亡组LYM绝对值(个/μL:650.24±84.67 vs. 876.64±38.02,P = 0.005)、CD3绝对值(个/μL:445.30±57.33 vs. 606.84±29.25,P = 0.006)、CD3CD4绝对值(个/μL:239.97±26.96 vs. 353.49±18.59,P = 0.001)、CD19绝对值(个/μL:111.10±18.66 vs. 150.30±10.15,P = 0.049)低于存活组。死亡组其他淋巴细胞亚群,如CD3CD8绝对值(个/μL:172.40±24.34 vs. 211.22±11.95,P = 0.112)、自然杀伤细胞绝对值[NK(个/μL):101.26±18.15 vs. 114.72±7.64,P = 0.420]、自然杀伤T细胞绝对值[NKT(个/μL):33.22±5.13 vs. 39.43±2.85,P = 0.262]、CD4CD8绝对值(个/μL:41.07±11.07 vs. 48.84±3.31,P = 0.510)、CD4CD8绝对值(个/μL:3.39±1.45 vs. 3.47±0.36,P = 0.943)与存活组无显著差异。(4)Logistic回归分析显示,淋巴细胞亚群未被选为对脓毒症预后具有统计学意义的免疫标志物。
脓毒症患者免疫指标的变化与其预后密切相关。早期监测上述指标可准确评估脓毒症患者的病情及预后。